FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/21/2025
Back to search
Official data from USPTO
THERALUGAND
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THERALUGAND
ST13
US500000079383213Class
1, 5, 42
Filing
79383213
Registration
7602399
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
04/03/2026
Trademark type
Word
Nice classes
1, 5, 42
Filing date
06/22/2023
Registration date
12/17/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/17/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
DE
Examiner
TWOHIG, SHANNON MARIE
Law office
N30
Current location
TMO LAW OFFICE 121
Holders and representatives
Holders
Eckert & Ziegler Radiopharma GmbH
Representatives
Ursula B. Day law firm of Ursula B. Day
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Industrial chemicals; radioactive elements for scientific purposes; detergents for use in manufacture of radioactive substances; salts for industrial purposes; chemical substances for analyses in laboratoriesother than for medical or veterinary purposes; diagnostic preparationsother than for medical or veterinary purposes; isotopes for industrial purposes; chemical reagents other than for medical or veterinary purposes; salts being chemical preparationsindustrial salts; fissionable chemical elementsradioactive elements for scientific purposes; emollients for industrial purposes; enzymes for scientific purposes; dyes for scientific or research purposes; glycoprotein; immunoglobulinsbeing biological preparations for scientific useother than for medical use; immunoassay reagents for scientific purposesother than for medical use; immunological antibodies for scientific purposesother than for medical use; biomolecule labeling kits comprising reagents for use in scientific research; laboratory reagents for scientific use; tagged antibodies for scientific use; tagged antibodies for laboratory use; monoclonal antibodies for scientific use; proteins in raw form for use in science; proteins in raw form for scientific purposes for binding antibodies other than for medical use; reagents for scientific purposes; substances for scientific useradioactive substances; universal reagents for automated test systems for scientific purposes; diagnostic reagents for scientific or research use
Class 5
Medical and veterinary preparationsradioactive preparations for use in treating cancer; biological reagents for medical use; biological reagents for veterinary use; diagnostic chemical reagents for medical use; diagnostic agents for pharmaceutical use; diagnostic biomarker reagents for medical purposes; immunoassay reagents for medical use; in vitro diagnostic preparations for medical use; clinical medical reagents; diagnostic reagents for medical use; clinical diagnostic reagents for medical or veterinary purposes; reagents for use in diagnostic pregnancy tests for medical or veterinary purposes; reagents and media for medical and veterinary diagnostic purposes; reagents for microbiological analysis for medical purposes; mineral salts for medical purposes; chemical preparations for medical purposesfor treatment of hormonal imbalances; chemical preparations for pharmaceutical purposesfor treatment of migraines; chemical preparations for veterinary purposeschemical reagents for veterinary use; chemico-pharmaceutical preparations for the treatment of gout; disinfectants; diagnostic preparations for medical use; pharmaceuticalveterinary and sanitary preparations for treatment of tumor diseases; radioactive substances for medical purposes
Class 42
Science and technology servicesscientific research services; testingauthentication and quality controltesting of pharmaceuticalsquality control for others; bacteriological consultation and research; consultancy in the field of pharmaceutical research; consultancy relating to laboratory testing of materials; biological researchclinical research in the field of chemotherapy and medical research; medical research laboratory services; analysis of human serum for medical research; research and development in the pharmaceutical and biotechnology fields; medical research laboratory services relating to the production of monoclonal antibodies; research and development services in the field of antibodies; pharmaceutical research and development; consultancy relating to biotechnology; biochemical analysis; biochemistry research services; biological research; microbiological testing; preparation of scientific research reports in the biotechnology field; research and development services in the field of immunology
Publications
History of USPTO decisions and trademark events.
33 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/31/2025
FIMP
FINAL DISPOSITION PROCESSED
05/31/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/03/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/15/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/15/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/21/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/18/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/17/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/29/2024
PUBO
PUBLISHED FOR OPPOSITION
10/29/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/09/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/18/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
09/16/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/16/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
09/16/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/16/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/12/2024
GNFR
FINAL REFUSAL E-MAILED
09/12/2024
CNFR
FINAL REFUSAL WRITTEN
09/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/10/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/09/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/09/2024
RFNT
REFUSAL PROCESSED BY IB
04/24/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/03/2024
RFRR
REFUSAL PROCESSED BY MPU
04/02/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/14/2024
CNRT
NON-FINAL ACTION WRITTEN
03/13/2024
DOCK
ASSIGNED TO EXAMINER
03/11/2024
MAFR
APPLICATION FILING RECEIPT MAILED
11/21/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/17/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/16/2023
Continuous trademark protection
Get notified about every new filing that threatens THERALUGAND or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.